{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:09Z","timestamp":1772119749995,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11060-024-04749-5","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T13:02:04Z","timestamp":1719838924000},"page":"671-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era"],"prefix":"10.1007","volume":"169","author":[{"given":"Kyril L.","family":"Cole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma R.","family":"Earl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Findlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon A.","family":"Sherrod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel A.","family":"Tenhoeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Kunzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald M.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wallace","family":"Akerley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Burt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth B.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2824-4221","authenticated-orcid":false,"given":"Randy L.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"4749_CR1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/B978-0-7020-4088-7.00077-8","volume":"121","author":"J Gallego Perez-Larraya","year":"2014","unstructured":"Gallego Perez-Larraya J, Hildebrand J (2014) Brain metastases. Handb Clin Neurol 121:1143\u20131157. https:\/\/doi.org\/10.1016\/B978-0-7020-4088-7.00077-8","journal-title":"Handb Clin Neurol"},{"key":"4749_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nec.2010.08.007","volume":"22","author":"BD Fox","year":"2011","unstructured":"Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G (2011) Epidemiology of metastatic brain tumors. Neurosurg Clin N Am 22:1\u20136. https:\/\/doi.org\/10.1016\/j.nec.2010.08.007","journal-title":"Neurosurg Clin N Am"},{"key":"4749_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/neuonc\/nou099","volume":"17","author":"J Villano","year":"2015","unstructured":"Villano J, Durbin E, Normandeau C, Thakkar J, Moirangthem V, Davis F (2015) Incidence of brain metastasis at initial presentation of lung cancer. Neuro Oncol 17:122\u2013128. https:\/\/doi.org\/10.1093\/neuonc\/nou099","journal-title":"Neuro Oncol"},{"key":"4749_CR4","doi-asserted-by":"publisher","first-page":"vdaa041","DOI":"10.1093\/noajnl\/vdaa041","volume":"2","author":"R Singh","year":"2020","unstructured":"Singh R, Stoltzfus KC, Chen H, Louie AV, Lehrer EJ, Horn SR, Palmer JD, Trifiletti DM, Brown PD, Zaorsky NG (2020) Epidemiology of synchronous brain metastases. Neurooncol Adv 2:vdaa041. https:\/\/doi.org\/10.1093\/noajnl\/vdaa041","journal-title":"Neurooncol Adv"},{"key":"4749_CR5","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.21037\/atm.2018.10.27","volume":"6","author":"JH Lim","year":"2018","unstructured":"Lim JH, Um SW (2018) The risk factors for brain metastases in patients with non-small cell lung cancer. Ann Transl Med 6:S66. https:\/\/doi.org\/10.21037\/atm.2018.10.27","journal-title":"Ann Transl Med"},{"key":"4749_CR6","first-page":"2574","volume":"38","author":"K Sawada","year":"1980","unstructured":"Sawada K (1980) [Lung cancer: classification by cell types]. Nihon Rinsho 38:2574\u20132580","journal-title":"Nihon Rinsho"},{"key":"4749_CR7","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.ijrobp.2012.08.007","volume":"85","author":"LM Halasz","year":"2013","unstructured":"Halasz LM, Weeks JC, Neville BA, Taback N, Punglia RS (2013) Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States. Int J Radiat Oncol Biol Phys 85:e109\u2013116. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.08.007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4749_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s13402-017-0345-5","volume":"40","author":"M Yousefi","year":"2017","unstructured":"Yousefi M, Bahrami T, Salmaninejad A, Nosrati R, Ghaffari P, Ghaffari SH (2017) Lung cancer-associated brain metastasis: molecular mechanisms and therapeutic options. Cell Oncol (Dordr) 40:419\u2013441. https:\/\/doi.org\/10.1007\/s13402-017-0345-5","journal-title":"Cell Oncol (Dordr)"},{"key":"4749_CR9","doi-asserted-by":"publisher","first-page":"CD003292","DOI":"10.1002\/14651858.CD003292.pub2","volume":"2005","author":"MG Hart","year":"2005","unstructured":"Hart MG, Grant R, Walker M, Dickinson H (2005) Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases. Cochrane Database Syst Rev 2005:CD003292. https:\/\/doi.org\/10.1002\/14651858.CD003292.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"4749_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3171\/2014.4.JNS13789","volume":"121","author":"TR Smith","year":"2014","unstructured":"Smith TR, Lall RR, Lall RR, Abecassis IJ, Arnaout OM, Marymont MH, Swanson KR, Chandler JP (2014) Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study. J Neurosurg 121:839\u2013845. https:\/\/doi.org\/10.3171\/2014.4.JNS13789","journal-title":"J Neurosurg"},{"key":"4749_CR11","first-page":"77","volume":"1","author":"LD Lunsford","year":"2011","unstructured":"Lunsford LD (2011) The development of the international stereotactic radiosurgery society. J Radiosurg SBRT 1:77\u201383","journal-title":"J Radiosurg SBRT"},{"key":"4749_CR12","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","volume":"363","author":"DW Andrews","year":"2004","unstructured":"Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665\u20131672. https:\/\/doi.org\/10.1016\/S0140-6736(04)16250-8","journal-title":"Lancet"},{"key":"4749_CR13","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1200\/EDBK_100006","volume":"35","author":"VA Venur","year":"2016","unstructured":"Venur VA, Ahluwalia MS (2016) Targeted therapy in brain metastases: ready for primetime? Am Soc Clin Oncol Educ Book 35:e123\u2013130. https:\/\/doi.org\/10.1200\/EDBK_100006","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"4749_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","volume":"3","author":"PW Sperduto","year":"2017","unstructured":"Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP (2017) Estimating survival in patients with Lung Cancer and Brain metastases: an update of the graded Prognostic Assessment for Lung Cancer using molecular markers (Lung-molGPA). JAMA Oncol 3:827\u2013831. https:\/\/doi.org\/10.1001\/jamaoncol.2016.3834","journal-title":"JAMA Oncol"},{"key":"4749_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1053\/clon.2001.9221","volume":"13","author":"B Jones","year":"2001","unstructured":"Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA (2001) The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol) 13:71\u201381. https:\/\/doi.org\/10.1053\/clon.2001.9221","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"4749_CR16","doi-asserted-by":"publisher","first-page":"107327482093628","DOI":"10.1177\/1073274820936287","volume":"27","author":"QY Zhuang","year":"2020","unstructured":"Zhuang QY, Li JL, Lin FF, Lin XJ, Lin H, Wang Y, Lin Y, Huang YX, Zhang XQ, Tang LR, Wu JX (2020) High biologically effective dose radiotherapy for brain metastases may improve survival and decrease risk for local relapse among patients with small-cell lung cancer: a propensity-matching analysis. Cancer Control 27:1073274820936287. https:\/\/doi.org\/10.1177\/1073274820936287","journal-title":"Cancer Control"},{"key":"4749_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ijrobp.2017.11.041","volume":"100","author":"L Chen","year":"2018","unstructured":"Chen L, Douglass J, Kleinberg L, Ye X, Marciscano AE, Forde PM, Brahmer J, Lipson E, Sharfman W, Hammers H, Naidoo J, Bettegowda C, Lim M, Redmond KJ (2018) Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma. Int J Radiat Oncol Biol Phys 100:916\u2013925. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.11.041","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4749_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fonc.2014.00248","volume":"4","author":"S Owen","year":"2014","unstructured":"Owen S, Souhami L (2014) The management of brain metastases in non-small cell lung cancer. Front Oncol 4:248. https:\/\/doi.org\/10.3389\/fonc.2014.00248","journal-title":"Front Oncol"},{"key":"4749_CR19","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3171\/2023.8.JNS23308","volume":"140","author":"GD Michalopoulos","year":"2024","unstructured":"Michalopoulos GD, Katsos K, Grills IS, Warnick RE, McInerney J, Attia A, Timmerman R, Chang E, Andrews DW, D\u2019Ambrosio AL, Cobb WS, Pouratian N, Spalding AC, Walter K, Jensen RL, Bydon M, Asher AL, Sheehan JP (2024) Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry. J Neurosurg 140:1223\u20131232. https:\/\/doi.org\/10.3171\/2023.8.JNS23308","journal-title":"J Neurosurg"},{"key":"4749_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3171\/2018.7.GKS181378","volume":"129","author":"T Shuto","year":"2018","unstructured":"Shuto T, Akabane A, Yamamoto M, Serizawa T, Higuchi Y, Sato Y, Kawagishi J, Yamanaka K, Jokura H, Yomo S, Nagano O, Aoyama H (2018) Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC). J Neurosurg 129:86\u201394. https:\/\/doi.org\/10.3171\/2018.7.GKS181378","journal-title":"J Neurosurg"},{"key":"4749_CR21","doi-asserted-by":"publisher","first-page":"e11777","DOI":"10.1097\/MD.0000000000011777","volume":"97","author":"S Qie","year":"2018","unstructured":"Qie S, Li Y, Shi HY, Yuan L, Su L, Zhang X (2018) Stereotactic radiosurgery (SRS) alone versus whole brain radiotherapy plus SRS in patients with 1 to 4 brain metastases from non-small cell lung cancer stratified by the graded prognostic assessment: a meta-analysis (PRISMA) of randomized control trials. Med (Baltim) 97:e11777. https:\/\/doi.org\/10.1097\/MD.0000000000011777","journal-title":"Med (Baltim)"},{"key":"4749_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1227\/neu.0000000000002640","volume":"94","author":"E Mashiach","year":"2024","unstructured":"Mashiach E, Alzate JD, De Nigris Vasconcellos F, Bernstein K, Donahue BR, Schnurman Z, Gurewitz J, Rotman LE, Adams S, Meyers M, Oratz R, Novik Y, Kwa MJ, Silverman JS, Sulman EP, Golfinos JG, Kondziolka D (2024) Long-term survival from breast Cancer Brain metastases in the era of modern systemic therapies. Neurosurgery 94:154\u2013164. https:\/\/doi.org\/10.1227\/neu.0000000000002640","journal-title":"Neurosurgery"},{"key":"4749_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3171\/2019.4.JNS19446","volume":"133","author":"CC Lee","year":"2019","unstructured":"Lee CC, Hsu SPC, Lin CJ, Wu HM, Chen YW, Luo YH, Chiang CL, Hu YS, Chung WY, Shiau CY, Guo WY, Hung-Chi Pan D, Yang HC (2019) Epidermal growth factor receptor mutations: association with favorable local tumor control following Gamma Knife Radiosurgery in patients with non-small cell lung cancer and brain metastases. J Neurosurg 133:313\u2013320. https:\/\/doi.org\/10.3171\/2019.4.JNS19446","journal-title":"J Neurosurg"},{"key":"4749_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3171\/2021.9.JNS211373","volume":"137","author":"GY Chiou","year":"2021","unstructured":"Chiou GY, Chiang CL, Yang HC, Shen CI, Wu HM, Chen YW, Chen CJ, Luo YH, Hu YS, Lin CJ, Chung WY, Shiau CY, Guo WY, Pan DH, Lee CC (2021) Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non-small cell lung cancer patients with brain metastases. J Neurosurg 137:563\u2013570. https:\/\/doi.org\/10.3171\/2021.9.JNS211373","journal-title":"J Neurosurg"},{"key":"4749_CR25","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1200\/JCO.2016.69.7144","volume":"35","author":"WJ Magnuson","year":"2017","unstructured":"Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, Beal K, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta LC, Balasubramanian SK, Ahluwalia MS, Rana NG, Attia A, Gettinger SN, Contessa JN, Yu JB, Chiang VL (2017) Management of brain metastases in tyrosine kinase inhibitor-naive epidermal growth factor receptor-mutant non-small-cell lung cancer: a retrospective multi-institutional analysis. J Clin Oncol 35:1070\u20131077. https:\/\/doi.org\/10.1200\/JCO.2016.69.7144","journal-title":"J Clin Oncol"},{"key":"4749_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3171\/2018.8.Jns182100","volume":"132","author":"A Juloori","year":"2019","unstructured":"Juloori A, Miller JA, Parsai S, Kotecha R, Ahluwalia MS, Mohammadi AM, Murphy ES, Suh JH, Barnett GH, Yu JS, Vogelbaum MA, Rini B, Garcia J, Stevens GH, Angelov L, Chao ST (2019) Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases. J Neurosurg 132:188\u2013196. https:\/\/doi.org\/10.3171\/2018.8.Jns182100","journal-title":"J Neurosurg"},{"key":"4749_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1200\/JOP.19.00357","volume":"15","author":"V Ernani","year":"2019","unstructured":"Ernani V, Stinchcombe TE (2019) Management of brain metastases in non-small-cell lung cancer. J Oncol Pract 15:563\u2013570. https:\/\/doi.org\/10.1200\/JOP.19.00357","journal-title":"J Oncol Pract"},{"key":"4749_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-021-03698-7","volume":"152","author":"AL Asher","year":"2021","unstructured":"Asher AL, Alvi MA, Bydon M, Pouratian N, Warnick RE, McInerney J, Grills IS, Sheehan J (2021) Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry. J Neurooncol 152:299\u2013311. https:\/\/doi.org\/10.1007\/s11060-021-03698-7","journal-title":"J Neurooncol"},{"key":"4749_CR29","doi-asserted-by":"publisher","first-page":"1216852","DOI":"10.3389\/fonc.2023.1216852","volume":"13","author":"T Chen","year":"2023","unstructured":"Chen T, Tang M, Zhou Y, Wang Z, Li S, Wang H, Lu Y, Wang J, Shen W (2023) Pretreatment lymphocyte-to-monocyte ratio as a prognostic factor and influence on dose-effect in fractionated stereotactic radiotherapy for oligometastatic brain metastases in non-small cell lung cancer patients. Front Oncol 13:1216852. https:\/\/doi.org\/10.3389\/fonc.2023.1216852","journal-title":"Front Oncol"},{"key":"4749_CR30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3171\/2021.10.JNS211410","volume":"137","author":"MA Alvi","year":"2022","unstructured":"Alvi MA, Asher AL, Michalopoulos GD, Grills IS, Warnick RE, McInerney J, Chiang VL, Attia A, Timmerman R, Chang E, Kavanagh BD, Andrews DW, Walter K, Bydon M, Sheehan JP (2022) Factors associated with progression and mortality among patients undergoing stereotactic radiosurgery for intracranial metastasis: results from a national real-world registry. J Neurosurg 137:985\u2013998. https:\/\/doi.org\/10.3171\/2021.10.JNS211410","journal-title":"J Neurosurg"},{"key":"4749_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3171\/2012.5.JNS111929","volume":"117","author":"JP Knisely","year":"2012","unstructured":"Knisely JP, Yu JB, Flanigan J, Sznol M, Kluger HM, Chiang VL (2012) Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg 117:227\u2013233. https:\/\/doi.org\/10.3171\/2012.5.JNS111929","journal-title":"J Neurosurg"},{"key":"4749_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fonc.2018.00154","volume":"8","author":"D Hartgerink","year":"2018","unstructured":"Hartgerink D, van der Heijden B, De Ruysscher D, Postma A, Ackermans L, Hoeben A, Anten M, Lambin P, Terhaag K, Jochems A, Dekker A, Schoenmaekers J, Hendriks L, Zindler J (2018) Stereotactic radiosurgery in the management of patients with brain metastases of non-small cell lung cancer: indications, decision tools and future directions. Front Oncol 8:154. https:\/\/doi.org\/10.3389\/fonc.2018.00154","journal-title":"Front Oncol"},{"key":"4749_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11060-023-04350-2","volume":"163","author":"J Sheehan","year":"2023","unstructured":"Sheehan J, Cifarelli CP, Fadul C (2023) Contemporary care for brain metastasis patients: multidisciplinary approaches and the role of prospective national registries. J Neurooncol 163:477\u2013479. https:\/\/doi.org\/10.1007\/s11060-023-04350-2","journal-title":"J Neurooncol"},{"key":"4749_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11060-023-04553-7","volume":"166","author":"JP Sheehan","year":"2024","unstructured":"Sheehan JP, Michalopoulos GD, Katsos K, Bydon M, Asher AL (2024) The NeuroPoint alliance SRS & tumor QOD registries. J Neurooncol 166:257\u2013264. https:\/\/doi.org\/10.1007\/s11060-023-04553-7","journal-title":"J Neurooncol"},{"key":"4749_CR35","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.3171\/2018.8.JNS181599","volume":"131","author":"JP Sheehan","year":"2018","unstructured":"Sheehan JP, Grills I, Chiang VL, Dong H, Berg A, Warnick RE, Kondziolka D, Kavanagh B (2018) Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry. J Neurosurg 131:1848\u20131854. https:\/\/doi.org\/10.3171\/2018.8.JNS181599","journal-title":"J Neurosurg"},{"key":"4749_CR36","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3171\/2020.4.JNS20788","volume":"134","author":"A Bunevicius","year":"2020","unstructured":"Bunevicius A, Lavezzo K, Shabo L, McClure J, Sheehan JP (2020) Quality-of-life trajectories after stereotactic radiosurgery for brain metastases. J Neurosurg 134:1791\u20131799. https:\/\/doi.org\/10.3171\/2020.4.JNS20788","journal-title":"J Neurosurg"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04749-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04749-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04749-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T10:42:34Z","timestamp":1724409754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04749-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4749"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04749-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4254056\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was a retrospective time-dependent analysis and was approved by the University of Utah institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The institutional review board approved this study with a waiver of informed consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"There is no identifying information included in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"Randy Jensen is a consultant for Medtronic. The remaining authors have no relevant financial or institutional interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}